Fed. Circ. Upholds PTAB Nix Of Blood-Clotting Patent

By Tiffany Hu (November 7, 2018, 8:55 PM EST) -- The Federal Circuit on Wednesday upheld a ruling by the Patent Trial and Appeal Board invalidating a patent for treating blood clotting by administering an active form of the blood thinner Plavix, agreeing with the board that the patent was obvious in light of prior art....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!